ADXN - Addex Therapeutics Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADXN is currently covered by 1 analysts with an average price target of $28.82. This is a potential upside of $20.72 (255.8%) from yesterday's end of day stock price of $8.1.

Addex Therapeutics Ltd's activity chart (see below) currently has 1 price targets and 5 ratings on display. The stock rating distribution of ADXN is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ADXN is $30, Lowest price target is $30, average price target is $30.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Oct-2024. First documented stock forecast 20-Apr-2021.

Best performing analysts who are covering ADXN - Addex Therapeutics Ltd:

Raghuram Selvaraju

Currently out of the existing stock ratings of ADXN, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$30

$21.9 (270.37%)

$30

7 months 10 days ago
(01-Oct-2024)

0/4 (0%)

$20.72 (223.28%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADXN (Addex Therapeutics Ltd) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ADXN (Addex Therapeutics Ltd) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on ADXN (Addex Therapeutics Ltd)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on ADXN

Which analyst is the currently most bullish on ADXN (Addex Therapeutics Ltd)?

Raghuram Selvaraju with highest potential upside - $21.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?